OxThera

1 in Phase 3

Quick facts

Phase 3 pipeline

Oxabact OC5 - Oxalobacter formigenes HC-1 · Nephrology
Oxabact OC5 is a live biotherapeutic product that works by colonizing the gut with Oxalobacter formigenes HC-1, which degrades oxalate, reducing its absorption and systemic levels.

Phase 2 pipeline

Oxalobacter formigenes

Phase 1 pipeline

Oxabact OC5 capsules

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: